About Index Trending news
Analyze
Top 50 Pricing
Adimab, LLC

Adimab, LLC

Work at Adimab, LLC? Add yourself to this profile

Adimab, LLC

Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.

Elsewhere

Alexa global traffic share

03 Apr 2012
$14,000,000
Venture capital
22 Jan 2010
$8,200,000
Venture capital (Series D)
20 Nov 2008
$4,000,000
Venture capital (Series C)
21 Sep 2007
$5,900,000
Venture capital (Series A)